← Back to headlines
ViiV's Dovato Matches Gilead's Biktarvy in Clinical Trial
A head-to-head clinical trial has demonstrated that ViiV Healthcare's Dovato is as effective as Gilead Sciences' Biktarvy, indicating comparable efficacy between the two treatments.
27 Jul, 17:44 — 27 Jul, 17:44
Sources
Showing 1 of 1 sources
Related Stories
Signs of depression in teenagers that parents often overlook
8h ago
74-year-old woman dies after being pulled unconscious from sea in Katerini, Greece
8h ago
August Depression: Psychologists Advise on Coping with End-of-Summer Sadness
8h ago
Heat Warnings Overlook Common Health Problems Exacerbated by Extreme Temperatures
8h ago